A double-blind study of the efficacy and safety of sertraline and clomipramine in outpatients with severe major depression

International Clinical Psychopharmacology

Volumn 15, Issue 5, 2000, Pages 263-271

  Lepine, J P ^a   Goger, J ^a   Blashko, C ^a   Probst, C ^a   Moles, M F ^a   Kosolowski, J ^a   Scharfetter, B ^a   Lane, R M ^a  

^a PFIZER INC   (United States)

Author keywords

Clomipramine; Endogenous depression; Melancholia; Sertraline; Severe depression; Sleep

Indexed keywords

CLOMIPRAMINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP PATTERN; TREATMENT OUTCOME; TREMOR; VERTIGO; XEROSTOMIA;

EID: 0033841438     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200015050-00003     Document Type: Article

References (40)

1. Selective serotonin reuptake inhibitor efficacy in severe and melancholic depression
2. Blockade by newly developed antidepressants of biogenic amine uptake into rat brain synaptosomes
3. Citalopram: Clinical effect profile in comparison with clomipramine. A controlled multicenter study
4. A selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study
5. Changes in plasma prolactin during SSRI treatment: Evidence for a delayed increase in 5-HT neurotransmission
6. Sertraline safety and efficacy in major depression: A double-blind fixed-dose comparison with placebo
7. Predictors of an acute antidepressant response to fluoxetine and sertraline
8. Selective serotonin reuptake inhibitors in affective disorders. I. Basic pharmacology
9. Selective serotonin reuptake inhibitors in affective disorders. II. Efficacy and quality of life
10. Sertraline treatment does not increase plasma prolactin levels in healthy subjects
11. A rating scale for depression
12. Development of a rating scale for primary depressive illness
13. Antidepressant efficacy in relation to item analysis and severity of depression: A placebo-controlled trial of fluvoxamine versus imipramine
14. Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations
15. Lack of adverse interactions between concomitantly administered selegiline and citalopram
16. SSRI-induced extrapyramidal side effects and akathisia: Implications for treatment
17. A six month comparison of toleration and efficacy of sertraline and fluoxetine treatment of major depression
18. Practical aspects of long-term treatment
19. Pharmacotherapy of depressed patients. Increasing the therapeutic arsenal with a new generation of antidepressive drugs
20. Double-blind, multicenter comparative study of sertraline and amitriptyline in hospitalized patients with Major Depression
21. A new depression scale designed to be sensitive to change
22. Selective serotonin reuptake inhibitors: Meta-analysis of dicontinuation rates
23. A double-blind comparison of sertraline and clomipramine in the treatment of major depressive disorder and associated anxiety in general practice
24. A double-blind placebo-controlled multicentre study of sertraline on the acute and continuation treatment of major depression
25. Fluvoxamine and clomipramine in depressed hospitalised patients: Results from a randomised, double-blind study
26. Factor analysis of a sleep evaluation questionnaire
27. Pharmacotherapy for major depression with melancholic features: Relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants
28. A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group
29. Antidepressant efficacy of sertraline: A double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression
30. ComparatiVe efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia
31. Not so selective serotonin reuptake inhibitors
32. Dopamine receptors in the basal ganglia: Relevance to Parkinson's disease
33. Pharmacological profile of antidepressants and related compounds at human monoamine transporters
34. A selective serotonin reuptake inhibitor, fluoxetine hydrochloride, moderates the pulsatile release of prolactin in postmenopausal women
35. Double-blind controlled trial of sertraline verus paroxetine in the treatment of delusional depression